
Blackrock Neurotech offers MoveAgain BCI
FDA Breakthrough-designated implantable brain-computer interface system letting paralyzed patients control external devices through thought.
- Currently Offered

FDA Breakthrough-designated implantable brain-computer interface system letting paralyzed patients control external devices through thought.
Blackrock Neurotech's MoveAgain is an implantable brain-computer interface that places a microelectrode array in the motor cortex to decode neuronal firing patterns into commands for external devices — including mouse cursors, keyboards, wheelchairs, and prosthetic limbs. The system enables users to type at up to 90 characters per minute and received FDA Breakthrough Device Designation in November 2021, targeting the approximately 5.35 million Americans living with paralysis.
MoveAgain's platform draws on 25 years of human BCI studies, more than 30,000 implant-days of data, and over 2,000 peer-reviewed publications. Blackrock's NeuroPort Neural Signal Processor records up to 512 channels simultaneously and supports research in more than 1,000 laboratories across 53 countries, with clinical participants demonstrating thought-directed control of robotic arms, email, and everyday tasks.


Investigational wireless brain-computer interface designed to restore speech and computer control for people with motor impairment.


Implantable brain-computer interface with thousands of flexible electrode threads, enabling thought-based device control for paralyzed patients.

Investigational wireless brain-computer interface designed to restore speech and computer control for people with motor impairment.

Implantable brain-computer interface with thousands of flexible electrode threads, enabling thought-based device control for paralyzed patients.

Endovascular brain-computer interface implanted via the jugular vein, decoding motor cortex signals without open-skull surgery.



Minimally invasive cortical interface that records and stimulates at the brain's surface without penetrating tissue.


BIOS Health's neural interface and AI platform reads and writes neural data to discover neural biomarkers for precision medicine.
Minimally invasive cortical interface that records and stimulates at the brain's surface without penetrating tissue.

BIOS Health's neural interface and AI platform reads and writes neural data to discover neural biomarkers for precision medicine.
